These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8493865)
41. Marrow transplant experience for children with severe aplastic anemia. Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172 [TBL] [Abstract][Full Text] [Related]
42. Bone marrow transplantation for severe aplastic anemia. Lin KH; Chen YC; Lin DT; Lui LT; Wang CH; Lin KS J Formos Med Assoc; 1993 Dec; 92(12):1070-5. PubMed ID: 7911356 [TBL] [Abstract][Full Text] [Related]
43. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434 [TBL] [Abstract][Full Text] [Related]
44. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation. Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T Jpn J Clin Oncol; 1992 Aug; 22(4):238-43. PubMed ID: 1359173 [TBL] [Abstract][Full Text] [Related]
45. Dendritic abnormalities in patients with subacute sclerosing panencephalitis (SSPE). A Golgi study. Paula-Barbosa MM; Tavares MA; Saraiva AA Acta Neuropathol; 1980; 52(1):77-80. PubMed ID: 7435159 [TBL] [Abstract][Full Text] [Related]
46. [An analysis of sclerodermatous graft-versus-host-disease after allogeneic bone marrow transplantation: CD8+CD57+T-cell proliferation and increased production of TGF-beta]. Nakazawa Y; Koike K; Kitazawa Y; Sakashita K; Sawai N; Matsumoto K; Ito S; Kumagai T; Yamada M; Komiyama A Rinsho Ketsueki; 1998 Mar; 39(3):185-92. PubMed ID: 9577641 [TBL] [Abstract][Full Text] [Related]
47. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361 [TBL] [Abstract][Full Text] [Related]
48. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect. Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385 [TBL] [Abstract][Full Text] [Related]
49. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT). Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051 [TBL] [Abstract][Full Text] [Related]
50. The distribution of Alzheimer's neurofibrillary tangles and gliosis in chronic subacute sclerosing panencephalitis. Mandybur TI Acta Neuropathol; 1990; 80(3):307-10. PubMed ID: 1698006 [TBL] [Abstract][Full Text] [Related]
51. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89. Hows JM; Chapple M; Marsh JC; Durrant S; Yin JL; Swirsky D; Gordon-Smith EC Bone Marrow Transplant; 1989 Nov; 4(6):629-34. PubMed ID: 2684308 [TBL] [Abstract][Full Text] [Related]
52. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Niederwieser D; Pepe M; Storb R; Witherspoon R; Longton G; Sullivan K Bone Marrow Transplant; 1989 Mar; 4(2):151-6. PubMed ID: 2650784 [TBL] [Abstract][Full Text] [Related]
53. CNS angiitis in graft vs host disease. Ma M; Barnes G; Pulliam J; Jezek D; Baumann RJ; Berger JR Neurology; 2002 Dec; 59(12):1994-7. PubMed ID: 12499502 [TBL] [Abstract][Full Text] [Related]
54. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303 [TBL] [Abstract][Full Text] [Related]
55. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation]. Prager J; Baumert A; Hermann J; Fuchs D; Zintl F Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263 [TBL] [Abstract][Full Text] [Related]
56. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095 [TBL] [Abstract][Full Text] [Related]
57. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Crawford SW; Longton G; Storb R Bone Marrow Transplant; 1993 Sep; 12(3):225-31. PubMed ID: 8241981 [TBL] [Abstract][Full Text] [Related]